Details of the Drug
General Information of Drug (ID: DMRKO49)
Drug Name |
Ribose-5-Phosphate
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
ribose-5-phosphate; Ribose phosphate; Ribose 5-monophosphate; 5-O-phosphono-D-ribose; D-ribose-5-phosphoric acid; D-Ribose 5-(dihydrogen phosphate); 4300-28-1; R-5-P; UNII-4B2428FLTO; Ribose, 5-(dihydrogen phosphate), D-; D-ribose-5-phosphate; 4B2428FLTO; aldehydo-D-ribose 5-phosphate; [(2R,3R,4R)-2,3,4-trihydroxy-5-oxopentyl] dihydrogen phosphate; R52; EINECS 224-310-2; AC1Q6RUZ; bmse000278; AC1L2U8E; D-Ribose 5-phosphoric acid; SCHEMBL21609; 3615-55-2; CTK1D6888; CHEBI:17797; Ribose, 5-(dihydrogen phosphate)
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 230.11 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -3.4 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 6 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 5 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 8 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||